Celvestrant 250 mg PFS
123,52$
80,13$
Celvestrant 250 mg PFS is a targeted injection designed to combat breast cancer in postmenopausal women, specifically effective for those with hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative types of the disease. This innovative treatment can be used in conjunction with palbociclib for patients experiencing locally advanced or metastatic breast cancer who have previously undergone endocrine therapy. Celvestrant works by inhibiting estrogen's effects, thereby slowing down the proliferation of cancer cells and potentially improving patient outcomes. It is essential to monitor for possible side effects and consult healthcare professionals for guidance on its use, especially in patients with liver issues or those taking other medications. Due to its specific application in treating advanced breast cancer, Celvestrant represents a vital option for patients seeking effective management of their condition. By targeting the hormonal pathways that fuel cancer growth, this injection not only aids in controlling the disease but also enhances the overall treatment landscape for women facing this challenging diagnosis. As with any anticancer therapy, discussing individual risks and benefits with a healthcare provider is crucial to ensure safe and effective treatment.
Quantité
Active Pharmaceutical Ingredient
Uses
• Celvestrant 250 mg pfs is primarily indicated for the treatment of hormone receptor-positive breast cancer in postmenopausal women. This medication works by targeting and blocking estrogen receptors, which can help slow down or stop the growth of certain breast tumors. Patients often receive Celvestrant 250 mg pfs when their cancer has progressed despite other hormonal therapies. This targeted approach can provide a valuable option for managing advanced disease.
• In addition to its role in treating advanced breast cancer, Celvestrant 250 mg pfs may be used in patients with locally advanced disease who are not candidates for surgery. The therapy aims to reduce tumor size, potentially making surgical intervention more feasible. By managing the symptoms and progression of the disease, Celvestrant 250 mg pfs can significantly improve the quality of life for these patients. This makes it a critical part of the treatment strategy in complex cases.
• Celvestrant 250 mg pfs is also beneficial for patients experiencing disease progression after prior endocrine treatments. It provides an alternative mechanism of action compared to other therapies, which can be crucial for those who have developed resistance. By incorporating Celvestrant 250 mg pfs into their treatment regimen, healthcare providers can offer patients renewed hope in their battle against breast cancer. This versatility in treatment options allows for more personalized patient care.
• Physicians may recommend Celvestrant 250 mg pfs as part of a combination therapy approach in select cases. When used alongside other anticancer agents, it can enhance overall treatment efficacy and potentially lead to better patient outcomes. The addition of Celvestrant 250 mg pfs can address specific tumor characteristics and improve response rates. This collaborative approach is essential in the ongoing fight against breast cancer.
Benefits
Celvestrant PFS Injection effectively reduces the symptoms associated with breast cancer, such as breast lumps, bloody nipple discharge, or changes in the shape or texture of the breast. Its mechanism of action involves altering the production of hormones that are essential for the growth and metastasis of breast cancer cells. It may also interact with other hormones or directly inhibit cancer growth. It is essential to receive Fulvestrant Injection 250 mg by injection from a doctor or nurse as self-administration is not recommended.It is important to look at your doctor's instructions carefully.
Side Effects
As with all medicines, Celvestrant 250 mg PFS may cause some side effects. If you experience any of these side effects, you should contact your doctor or health care professional as soon as possible. Your doctor may be able to suggest ways in which these side effects can be managed or the severity of them reduced.
Most Common Side Effects
• Back pain
• Diarrhoea
• Vaginal bleeding
• Muscle and Joint pain
• Reaction in the injection site
• Vomiting
• Nausea
• Numbness
• Appetite loss
• Sweating
• Infection in the urinary tract
Common Side Effects
• Blood clots
• Low platelets count
• Liver failure
• Swelling in tongue, mouth, throat, and face
How To Use
The Celvestrant 250 mg PFS is administered by a healthcare professional or nurse in a hospital or clinic setting by intravenous infusion under the skin. The specific dosage and administration of Anti-cancer Drug Celvestrant will be determined by the patient's clinical condition, age, medical history, and other factors. It is important to note that this Celvestrant 250 mg should not be self-administered, and it is important to follow the instructions of the healthcare professional administering the Celvestrant 250 mg PFS.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Celvestrant PFS Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Celvestrant 250 mg should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Celvestrant 250 mg PFS and report any unusual symptoms or changes in kidney function to their doctor. The dose of Celvestrant 250 mg may need to be adjusted in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Fulvestrant Injection 250 mg. Celvestrant PFS Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Celvestrant 250 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Fulvestrant Injection 250 mg should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Celvestrant 250 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Fulvestrant Injection 250 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Celvestrant 250 mg PFS may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Celvestrant 250 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Celvestrant 250 mg PFS is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Fulvestrant Injection 250 mg such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.